TOP STORIES

• REGULATORY Japan Weighs Pre-Approval Purchase of Shionogi’s COVID-19 Pill
  February 21, 2022

• BUSINESS Chugai Claims 1st-Ever Title in Japan Pharma Market in 2021 on Brisk Oncologic Performance: IQVIA
  February 18, 2022

• BUSINESS Sawai to Launch Teribone Generic as Court Invalidates Patents; Asahi Kasei to Challenge Ruling
  February 17, 2022

• REGULATORY Japan Approves Slew of Generics towards June Listing; Samsca, Xarelto AGs Too
  February 16, 2022

• BUSINESS Pharma Officials Air Hopes and Concerns as Japan Moves to Enhance Supply Chain for Economic Security
  February 15, 2022

• REGULATORY Japan Snags 10 Million Extra Doses of Pfizer Vaccine
  February 15, 2022

• BUSINESS Chugai Joins Top Ranks in Japan Sales on Ronapreve Boon, Roche Collaboration
  February 14, 2022

• REGULATORY Pfizer’s Paxlovid Contraindicated with Many Medicines, Requires Careful Use
  February 14, 2022

• REGULATORY Japan Approves Pfizer’s Paxlovid, Second Oral COVID-19 Pill
  February 10, 2022

• ORGANIZATION Govt-Industry Arrangement for Drug Supply Survey Hits Rough Waters; FPMAJ Stands Pat on Continued Dialogue
  February 10, 2022

• REGULATORY Chuikyo Issues 2022 Reform Recommendation; Patch Prescription Limit Lowered to 63 Sheets
  February 10, 2022

• BUSINESS Chugai Sees Huge Potential in Its RAS Inhibitor with 15% of All Cancers Targeted: Research Chief
  February 9, 2022

• BUSINESS Insmed Plots Growth in Japan Biz with Arikayce and More Drugs to Follow
  February 8, 2022

• BUSINESS Shionogi Looks to File COVID Pill in Japan as Early as Next Week
  February 8, 2022

• REGULATORY Japan Mulls Early Conditional Approval for Shionogi’s COVID Pill
  February 8, 2022

• BUSINESS Pharma Industry Frets Cost and Deadline of MHLW-Ordered Carcinogen Risk Inspections
  February 7, 2022

• REGULATORY Lilly’s Retevmo Clears PAFSC for Thyroid Cancer; Lenvima/Keytruda to Get RCC Indication
  February 7, 2022

• BUSINESS Novartis Japan Developing Iptacopan as Priority Product, Initially Targeting 3 Indications
  February 4, 2022

• REGULATORY Pfizer’s COVID-19 Pill Up for PAFSC Review on Feb. 10
  February 4, 2022

• REGULATORY 9 Drugs/6 APIs for Fertility Treatment to Be Listed in April; Generics Listing in June at the Earliest: Chuikyo
  February 3, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 77
• 78
• 79
• 80
• 81
• 82
• 83
• 84
• 85
• …
• Next ›
• 最終 »